MyAverix Finance
SHG · Healthcare
Cansino Biologics Inc (688185)
Drug Manufacturers - Specialty & Generic
Cansino Biologics Inc (688185) is listed on SHG in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-29, reported market cap is $16.80B, P/E ratio is 18.00, net margin is 2.6%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 688185
Cansino Biologics Inc (688185) — FAQ
What is Cansino Biologics Inc's market cap?
Cansino Biologics Inc (688185) has a reported market cap of $16.80B (data as of 2026-03-29).
What is 688185's P/E ratio?
The price-to-earnings (P/E) ratio for Cansino Biologics Inc (688185) is 18.00 (data as of 2026-03-29).
Does Cansino Biologics Inc pay a dividend?
Dividend yield is not available in the current snapshot for Cansino Biologics Inc (688185). Check the MyAverix Finance app for the latest dividend data.
What sector is Cansino Biologics Inc in?
Cansino Biologics Inc (688185) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 688185 listed on?
688185 is listed on SHG.
What is Cansino Biologics Inc's net margin?
Cansino Biologics Inc (688185) reports a net margin of 2.6% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.